Progressive, locally advanced radioactive iodine-refractory Differentiated Thyroid Cancer (DTC)
Drug | Drug Name | Drug Description |
---|---|---|
DB09078 | Lenvatinib | A receptor tyrosine kinase inhibitor used for the treatment of metastatic thyroid cancer, advanced renal cell carcinoma in combination with everolimus, and unresectable hepatocellular carcinoma. |
Drug | Drug Name | Phase | Status | Count |
---|